Easy Technologies Inc. ("Easy" or the "Company") and Shanghai Biotechnology Devices Limited ("Virax Biolabs") are pleased to announce that they have entered into a binding letter of intent to complete a business combination (the "Transaction"). The letter of intent was negotiated at arm's length and is effective as of April 22, 2021. Upon closing of the contemplated Transaction, the current board of directors of Easy shall resign.

Following completion of the contemplated Transaction, the officers of Virax Biolabs shall be the proposed and unchallenged nominees of Easy.